Home
>
National Drug Code (NDC)
>
Fludarabine Phosphate
Fludarabine Phosphate - 0703-5854-01 - (Fludarabine Phosphate)
Drug Information of Fludarabine Phosphate
| Product NDC: | 0703-5854 |
| Proprietary Name: | Fludarabine Phosphate |
| Non Proprietary Name: | Fludarabine Phosphate |
| Active Ingredient(s): | 50 mg/2mL & nbsp; Fludarabine Phosphate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fludarabine Phosphate
| Product NDC: | 0703-5854 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076349 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030912 |
Package Information of Fludarabine Phosphate
| Package NDC: | 0703-5854-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5854-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Fludarabine Phosphate
| NDC Code | 0703-5854-01 |
| Proprietary Name | Fludarabine Phosphate |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5854-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0703-5854 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fludarabine Phosphate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20030912 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | FLUDARABINE PHOSPHATE |
| Strength Number | 50 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
